ATE199561T1 - Chelatbildende gruppen enthaltende somastotatin- analoge und deren radiomarkiertezusammensetzungen - Google Patents

Chelatbildende gruppen enthaltende somastotatin- analoge und deren radiomarkiertezusammensetzungen

Info

Publication number
ATE199561T1
ATE199561T1 AT95810545T AT95810545T ATE199561T1 AT E199561 T1 ATE199561 T1 AT E199561T1 AT 95810545 T AT95810545 T AT 95810545T AT 95810545 T AT95810545 T AT 95810545T AT E199561 T1 ATE199561 T1 AT E199561T1
Authority
AT
Austria
Prior art keywords
somastotatin
radiom
forming groups
analogues containing
containing chelate
Prior art date
Application number
AT95810545T
Other languages
English (en)
Inventor
Rainer Albert
Christian Bruns
Peter Smith-Jones
Barbara Stolz
Gisbert Weckbecker
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE199561T1 publication Critical patent/ATE199561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95810545T 1994-09-06 1995-09-04 Chelatbildende gruppen enthaltende somastotatin- analoge und deren radiomarkiertezusammensetzungen ATE199561T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9417873A GB9417873D0 (en) 1994-09-06 1994-09-06 Organic compounds

Publications (1)

Publication Number Publication Date
ATE199561T1 true ATE199561T1 (de) 2001-03-15

Family

ID=10760870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95810545T ATE199561T1 (de) 1994-09-06 1995-09-04 Chelatbildende gruppen enthaltende somastotatin- analoge und deren radiomarkiertezusammensetzungen

Country Status (31)

Country Link
US (2) US6183721B1 (de)
EP (1) EP0714911B1 (de)
JP (1) JP3054346B2 (de)
KR (1) KR100364111B1 (de)
CN (1) CN1185252C (de)
AT (1) ATE199561T1 (de)
AU (1) AU703057B2 (de)
BR (1) BR9503936A (de)
CA (1) CA2157530C (de)
CO (1) CO4410344A1 (de)
CZ (1) CZ287012B6 (de)
DE (1) DE69520256T2 (de)
DK (1) DK0714911T3 (de)
ES (1) ES2157309T3 (de)
FI (1) FI117424B (de)
GB (1) GB9417873D0 (de)
GR (1) GR3035997T3 (de)
HU (1) HU218284B (de)
IL (1) IL115154A (de)
NO (1) NO316569B1 (de)
NZ (1) NZ272919A (de)
PE (1) PE41496A1 (de)
PL (1) PL182434B1 (de)
PT (1) PT714911E (de)
RU (1) RU2156774C2 (de)
SG (1) SG50356A1 (de)
SI (1) SI0714911T1 (de)
SK (1) SK283774B6 (de)
TR (1) TR199501094A2 (de)
TW (1) TW387898B (de)
ZA (1) ZA957475B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
AT405906B (de) * 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
US6358491B1 (en) 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
MX368013B (es) 2001-02-19 2019-09-13 Novartis Ag Tratamiento de cáncer.
CZ20032597A3 (cs) * 2001-02-26 2004-12-15 Bristol-Myers Squibb Pharma Company Analogy kyseliny askorbové pro metaloradiofarmaceutika
BR0210915A (pt) * 2001-06-08 2004-06-08 Sod Conseils Rech Applic Análogos quiméricos de somatostatina-dopamina
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
UA81634C2 (ru) 2002-07-18 2008-01-25 Хеликс Биофарма Корп. Фармацевтическая композиция уреазы для ингибирования роста раковых клеток и ее применение
CA2518406A1 (en) * 2003-03-10 2004-09-23 Biogen Idec Ma Inc. Thiol-mediated drug attachment to targeting peptides
US7632924B2 (en) 2004-06-18 2009-12-15 Ambrx, Inc. Antigen-binding polypeptides and their uses
US20100029911A1 (en) * 2004-11-24 2010-02-04 Aplagen Gmbh Method For Solid-Phase Peptide Synthesis And Purification
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
CN105388287A (zh) 2011-03-11 2016-03-09 内布拉斯加大学董事委员会 冠状动脉疾病的生物标志物
US9480759B2 (en) 2012-11-21 2016-11-01 Serene, Llc Tin-117m somatostatin receptor binding compounds and methods
CN103275189B (zh) * 2013-06-06 2014-08-06 深圳翰宇药业股份有限公司 一种用于肽树脂的裂解液及其在固相裂解合成生长抑素中的应用
EP3456700A1 (de) * 2013-10-18 2019-03-20 Deutsches Krebsforschungszentrum Markierte inhibitoren des prostataspezifischen membranantigens (psma), deren verwendung als kontrastmittel und pharmazeutika zur behandlung von prostatakrebs
SI3383920T1 (sl) 2015-11-30 2024-06-28 The Regents Of The University Of California Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic
EP3503930B1 (de) 2016-08-29 2024-12-11 Fred Hutchinson Cancer Center Chelatbildende plattform zur abgabe von radionukliden
WO2018089829A1 (en) 2016-11-10 2018-05-17 Fortis Therapeutics, Inc. Cd46-specific effector cells and uses thereof
HRP20231458T1 (hr) 2017-01-12 2024-05-10 Radiomedix Inc. Liječenje stanica raka koje prekomjerno eksprimiraju receptore za somatostatin primjenom derivata oktreotida keliranih sa radioizotopima
TW202547563A (zh) * 2018-06-21 2025-12-16 德商愛利穆治療有限公司 用於放射性醫藥之含有體抑素類似物之組成物
TW202015744A (zh) * 2018-06-21 2020-05-01 法商艾普森藥品公司 用於放射性醫藥之含有體抑素類似物之組成物
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US10596278B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
CN114096264B (zh) 2019-05-20 2025-03-14 因多塞特股份有限公司 制备psma缀合物的方法
EP4192511A1 (de) 2020-08-07 2023-06-14 Fortis Therapeutics, Inc. Gegen cd46 gerichtete immunkonjugate und verfahren zur verwendung davon
CN121793988A (zh) 2023-09-13 2026-04-03 东丽株式会社 癌的治疗、预防和/或诊断用药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US5006643A (en) 1987-06-24 1991-04-09 The Dow Chemical Company Process for preparing isothiocyanato functionalized metal complexes
DE3728600A1 (de) 1987-08-27 1989-03-09 Hoechst Ag Verfahren zur markierung von substanzen mit technetium oder rhenium
JPH0720989B2 (ja) * 1988-05-25 1995-03-08 アメリカ合衆国 大環状キレート化合物の抱合体と診断的テスト方法
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
ATE136224T1 (de) 1989-09-29 1996-04-15 Neorx Corp Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten
CA2131315A1 (en) * 1992-03-25 1993-09-30 Geert J. Ensing Method of intraoperatively detecting and locating tumoral tissues
NO940080L (no) * 1993-01-12 1994-07-13 Sandoz Ag Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2179990A1 (en) * 1994-01-12 1995-07-20 Gary Robert Bower Biological targeting agents
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
PL182434B1 (pl) 2002-01-31
ES2157309T3 (es) 2001-08-16
JPH0881498A (ja) 1996-03-26
AU3041495A (en) 1996-03-21
BR9503936A (pt) 1996-09-24
CZ287012B6 (en) 2000-08-16
PL310274A1 (en) 1996-03-18
SK108895A3 (en) 1996-06-05
SK283774B6 (sk) 2004-01-08
NO316569B1 (no) 2004-02-23
DE69520256T2 (de) 2001-08-09
GB9417873D0 (en) 1994-10-26
EP0714911A3 (de) 1996-08-21
CN1127259A (zh) 1996-07-24
US6277356B1 (en) 2001-08-21
EP0714911B1 (de) 2001-03-07
KR100364111B1 (ko) 2003-02-05
GR3035997T3 (en) 2001-09-28
HUT72895A (en) 1996-06-28
FI954147L (fi) 1996-03-07
HU218284B (en) 2000-07-28
IL115154A0 (en) 1995-12-31
NO953457D0 (no) 1995-09-04
DE69520256D1 (de) 2001-04-12
AU703057B2 (en) 1999-03-11
SI0714911T1 (en) 2001-08-31
PE41496A1 (es) 1996-10-14
IL115154A (en) 2000-08-13
RU2156774C2 (ru) 2000-09-27
SG50356A1 (en) 2000-11-21
TW387898B (en) 2000-04-21
KR960010683A (ko) 1996-04-20
ZA957475B (en) 1997-03-06
HU9502577D0 (en) 1995-11-28
US6183721B1 (en) 2001-02-06
NZ272919A (en) 1996-12-20
PT714911E (pt) 2001-08-30
EP0714911A2 (de) 1996-06-05
FI117424B (fi) 2006-10-13
CA2157530A1 (en) 1996-03-07
FI954147A0 (fi) 1995-09-04
JP3054346B2 (ja) 2000-06-19
CN1185252C (zh) 2005-01-19
CA2157530C (en) 2007-04-03
TR199501094A2 (tr) 1996-06-21
CO4410344A1 (es) 1997-01-09
DK0714911T3 (da) 2001-07-09
NO953457L (no) 1996-03-07
CZ226395A3 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
ATE199561T1 (de) Chelatbildende gruppen enthaltende somastotatin- analoge und deren radiomarkiertezusammensetzungen
NZ216632A (en) Multi-component, aqueous polymer compositions containing c 16 + aliphatic surface active compound as evaporation retarding agent
DE68906231D1 (de) Biozide verbindungen.
DE3682711D1 (de) Als fungizide verwendbare heterocyclische verbindungen.
DE3583334D1 (de) Borverbindungen enthaltende polycarbonatzusammensetzungen.
IT1190369B (it) Composizioni covulcanizzabili di fluoroelastomeri a migliorata stabilita' chimica
DE3784566D1 (de) Bisphenolverbindungen enthaltende zusammensetzungen.
GB2024805B (en) 1,3-di-n-decyl-2-methyl-imidazolium chloride or bromide and mictrobicidal composition containing this compound
FR2582306B1 (fr) Sels d'acides n-acyl-thiazolidine-4-carboxyliques et de 6-piperidino-2,4-diaminopyrimidine-3-oxyde et compositions a usage cosmetique-dermatologique les contenant
EP0182232A3 (en) Conditioning hair care composition
NO154754C (no) Stoepeasfaltblanding inneholdende syntetisk zeolitt.
EP0288969A3 (en) Antiulcer composition
IT1190386B (it) Composizioni covulcanizzabili di fluoroelastomeri a migliorata stabilita' chimica
PH18442A (en) 3-azolyl-1,2-diaryl-1-halo-1-propenes,their manufacture,their use as plant protecting agents and formulations containing these compounds
FI893577A7 (fi) Substituoidun aminobentsoaldehydin sisältäviä vetyperoksidikoostumuksia
ZA859706B (en) Organic compounds and their pharmaceutical use
BR8703792A (pt) Composicao de resina
AU640085B2 (en) Antimony, arsenic, boron and phosphorous halide salts of oxazolidinium compounds and resin compositions containing the same
IL91482A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
BE886452A (fr) Compositions durcissables par l'oxygene, catalysees par des composes metal-carbonyle
IL91480A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
IL91481A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
DE3464598D1 (en) Acetylene derivatives having an enzyme-inhibiting activity, their preparation and their use as medicines
SE8800003D0 (sv) Massablandning,saett att framstaella ett absorptionsmedel av massablandningen,samt saalunda framstaellt absorptionsmedel
BR9006562A (pt) Composicoes foto-curaveis contendo ureia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification